Header Logo

James Moy

Concepts (199)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
18
2021
156
2.170
Why?
Antibodies, Viral
6
2022
55
1.400
Why?
Immunoglobulin G
8
2022
80
1.350
Why?
Immunoglobulins, Intravenous
4
2018
19
0.960
Why?
Antibody Formation
2
2022
17
0.950
Why?
Salivary alpha-Amylases
1
2023
3
0.830
Why?
Viral Vaccines
1
2022
3
0.810
Why?
Vaccines
1
2022
8
0.810
Why?
Immunologic Deficiency Syndromes
3
2017
8
0.780
Why?
Agammaglobulinemia
2
2018
2
0.740
Why?
Common Variable Immunodeficiency
2
2018
5
0.740
Why?
Bacterial Infections
3
2018
51
0.710
Why?
Genetic Diseases, X-Linked
1
2018
1
0.590
Why?
Immunoglobulins
1
2017
14
0.560
Why?
Immunologic Factors
1
2017
29
0.550
Why?
Child, Preschool
12
2019
641
0.550
Why?
Immunotherapy
1
2017
58
0.550
Why?
Biomarkers
6
2023
562
0.540
Why?
Humans
39
2023
27072
0.520
Why?
Fluticasone
4
2019
4
0.510
Why?
Child
12
2021
1295
0.470
Why?
Adrenal Cortex Hormones
5
2019
115
0.440
Why?
Glucocorticoids
4
2019
68
0.430
Why?
Precision Medicine
3
2021
26
0.400
Why?
Respiratory Sounds
2
2019
9
0.380
Why?
Bronchodilator Agents
3
2019
13
0.360
Why?
Female
22
2021
15212
0.350
Why?
Male
21
2021
14772
0.340
Why?
Adolescent
9
2019
2172
0.340
Why?
Adult
13
2021
7831
0.330
Why?
Salmeterol Xinafoate
2
2019
2
0.320
Why?
Alendronate
2
2019
7
0.320
Why?
Ibuprofen
2
2021
11
0.310
Why?
NF-kappa B
3
2022
113
0.290
Why?
Double-Blind Method
9
2021
406
0.280
Why?
Middle Aged
10
2021
8923
0.280
Why?
Saliva
2
2023
52
0.280
Why?
Young Adult
6
2019
1994
0.280
Why?
Anti-Asthmatic Agents
4
2018
31
0.270
Why?
Administration, Inhalation
7
2019
37
0.260
Why?
Antibodies, Neutralizing
2
2022
20
0.250
Why?
Eosinophilia
2
2017
39
0.220
Why?
Cockroaches
1
2003
2
0.220
Why?
Respiratory Hypersensitivity
1
2003
4
0.220
Why?
Allergens
1
2003
16
0.220
Why?
Acetaminophen
3
2021
24
0.210
Why?
Nucleocapsid
1
2022
2
0.210
Why?
Neutralization Tests
1
2022
8
0.200
Why?
beta-Glucans
1
2022
24
0.200
Why?
Sputum
2
2019
21
0.190
Why?
Health Personnel
1
2022
94
0.190
Why?
Pandemics
2
2021
236
0.190
Why?
Immunity, Innate
1
2021
57
0.180
Why?
Infant
6
2018
564
0.180
Why?
Lung
2
2019
168
0.170
Why?
Prospective Studies
4
2019
1778
0.170
Why?
Cohort Studies
3
2021
1890
0.170
Why?
Education, Medical, Continuing
1
2020
33
0.170
Why?
Adrenergic beta-2 Receptor Agonists
1
2019
3
0.170
Why?
Hypersensitivity
1
2020
47
0.160
Why?
Randomized Controlled Trials as Topic
1
2021
292
0.160
Why?
Tiotropium Bromide
1
2019
2
0.160
Why?
Mometasone Furoate
1
2019
8
0.160
Why?
Receptors, Adrenergic, beta-2
1
2019
3
0.160
Why?
Betacoronavirus
1
2020
74
0.160
Why?
Vitamin A Deficiency
1
2018
1
0.160
Why?
Eosinophils
1
2019
44
0.150
Why?
Contrast Sensitivity
1
2018
6
0.150
Why?
Vitamin A
1
2018
8
0.150
Why?
Longitudinal Studies
1
2022
1368
0.150
Why?
Zinc
1
2018
42
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
18
0.150
Why?
Coronavirus Infections
1
2020
86
0.150
Why?
Pneumonia, Viral
1
2020
90
0.150
Why?
Glutathione
1
2018
22
0.150
Why?
Arginine
1
2018
17
0.150
Why?
HIV Infections
1
2022
466
0.140
Why?
Leukotriene Antagonists
1
2016
1
0.130
Why?
Inhalation Exposure
2
2008
5
0.130
Why?
Treatment Outcome
4
2018
3485
0.130
Why?
Sensitivity and Specificity
3
2022
482
0.130
Why?
Postoperative Complications
1
2022
916
0.130
Why?
Azithromycin
1
2015
2
0.130
Why?
Respiratory Tract Infections
1
2015
25
0.120
Why?
Secondary Prevention
1
2015
51
0.120
Why?
Research Design
3
2021
185
0.120
Why?
Pregnenediones
1
2014
3
0.110
Why?
Vitamins
1
2014
19
0.110
Why?
Cholecalciferol
1
2014
7
0.110
Why?
Vitamin D Deficiency
1
2014
10
0.110
Why?
Recurrence
3
2016
310
0.110
Why?
Severity of Illness Index
3
2021
879
0.100
Why?
Anti-Bacterial Agents
1
2015
370
0.100
Why?
Cotinine
2
2011
5
0.100
Why?
Dose-Response Relationship, Drug
3
2019
333
0.100
Why?
Quality of Life
1
2017
629
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2023
8
0.100
Why?
Dermatitis, Allergic Contact
1
2011
5
0.090
Why?
Pruritus
1
2011
10
0.090
Why?
Silicones
1
2011
11
0.090
Why?
Catheters, Indwelling
1
2011
23
0.090
Why?
Peritoneal Dialysis
1
2011
26
0.090
Why?
Mexican Americans
1
2011
26
0.090
Why?
Follow-Up Studies
3
2018
1792
0.090
Why?
Inflammation
2
2022
272
0.080
Why?
Prevalence
2
2018
443
0.080
Why?
Smoking
1
2011
176
0.080
Why?
Aged
3
2018
8997
0.080
Why?
Cross-Over Studies
2
2019
64
0.080
Why?
Tobacco Smoke Pollution
1
2008
7
0.080
Why?
Leukocyte Count
2
2019
61
0.070
Why?
Case-Control Studies
2
2021
587
0.070
Why?
Albuterol
2
2018
15
0.070
Why?
Models, Biological
1
2008
322
0.070
Why?
Cross-Sectional Studies
3
2018
891
0.060
Why?
Quinolines
1
2005
8
0.060
Why?
Acetates
1
2005
16
0.060
Why?
Incidence
2
2018
759
0.060
Why?
Air Pollution, Indoor
1
2003
1
0.050
Why?
Pyroglyphidae
1
2003
2
0.050
Why?
Skin Tests
1
2003
6
0.050
Why?
Cats
1
2003
29
0.050
Why?
Urban Health
1
2003
22
0.050
Why?
Child Welfare
1
2003
16
0.050
Why?
Statistics as Topic
1
2003
105
0.050
Why?
Dogs
1
2003
167
0.050
Why?
Signal Transduction
2
2022
443
0.050
Why?
Sialic Acid Binding Immunoglobulin-like Lectins
1
2023
3
0.050
Why?
Killer Cells, Natural
1
2023
37
0.050
Why?
Hepatitis B e Antigens
1
2022
1
0.050
Why?
Hepatitis B Antibodies
1
2022
2
0.050
Why?
Antibodies
1
2023
46
0.050
Why?
Hepatitis B Surface Antigens
1
2022
5
0.050
Why?
Syk Kinase
1
2022
10
0.050
Why?
Lectins, C-Type
1
2022
50
0.050
Why?
Respiratory Syncytial Viruses
1
2002
1
0.050
Why?
Chemokines
1
2002
21
0.050
Why?
Serologic Tests
1
2022
9
0.050
Why?
Clinical Trials, Phase II as Topic
1
2021
20
0.050
Why?
Advisory Committees
1
2021
19
0.050
Why?
Clinical Protocols
1
2021
57
0.050
Why?
Gene Expression Regulation, Neoplastic
1
2002
116
0.050
Why?
Immunization, Passive
1
2021
11
0.050
Why?
United States
2
2018
2035
0.050
Why?
Seroepidemiologic Studies
1
2021
18
0.050
Why?
Immunoglobulin M
1
2021
12
0.050
Why?
Immunoglobulin Fc Fragments
1
2021
5
0.050
Why?
Complement Activation
1
2021
8
0.050
Why?
Receptors, Fc
1
2021
7
0.050
Why?
Antibody Specificity
1
2021
25
0.050
Why?
Spike Glycoprotein, Coronavirus
1
2021
17
0.050
Why?
Phagocytosis
1
2021
33
0.050
Why?
Tumor Necrosis Factor-alpha
1
2002
189
0.050
Why?
Administration, Oral
2
2014
108
0.040
Why?
Education, Distance
1
2020
16
0.040
Why?
Drug Combinations
1
2019
33
0.040
Why?
Adrenergic beta-Antagonists
1
2019
26
0.040
Why?
Proof of Concept Study
1
2019
12
0.040
Why?
Reproducibility of Results
1
2021
676
0.040
Why?
Medication Adherence
1
2019
49
0.040
Why?
Surveys and Questionnaires
1
2003
1144
0.040
Why?
Ornithine
1
2018
1
0.040
Why?
Peak Expiratory Flow Rate
1
2018
1
0.040
Why?
Growth
1
2018
6
0.040
Why?
Analgesics, Non-Narcotic
1
2018
17
0.040
Why?
Tomography, X-Ray Computed
1
2021
683
0.040
Why?
Forced Expiratory Volume
1
2017
10
0.030
Why?
Immunoglobulin E
1
2017
11
0.030
Why?
Chicago
2
2011
949
0.030
Why?
Fever
1
2016
34
0.030
Why?
Neutrophils
1
2017
104
0.030
Why?
Kaplan-Meier Estimate
1
2016
175
0.030
Why?
Animals
1
2003
3642
0.030
Why?
Phenotype
1
2017
312
0.030
Why?
Drug Administration Schedule
1
2015
158
0.030
Why?
Drug Resistance, Bacterial
1
2015
55
0.030
Why?
Treatment Failure
1
2014
158
0.030
Why?
Disease Progression
1
2015
673
0.030
Why?
Pain
1
2016
413
0.030
Why?
Patch Tests
1
2011
2
0.020
Why?
Exanthema
1
2011
12
0.020
Why?
Morbidity
1
2011
54
0.020
Why?
Regression Analysis
1
2011
260
0.020
Why?
Drug Evaluation
1
2009
20
0.020
Why?
Half-Life
1
2009
11
0.020
Why?
Drug Dosage Calculations
1
2009
6
0.020
Why?
Kidney Failure, Chronic
1
2011
124
0.020
Why?
Socioeconomic Factors
1
2008
302
0.020
Why?
Cyclopropanes
1
2005
9
0.020
Why?
Sulfides
1
2005
10
0.020
Why?
Adrenergic beta-Agonists
1
2005
16
0.020
Why?
Placebos
1
2005
65
0.020
Why?
Acetylcysteine
1
2002
14
0.010
Why?
Free Radical Scavengers
1
2002
8
0.010
Why?
Oxidation-Reduction
1
2002
65
0.010
Why?
Tumor Cells, Cultured
1
2002
129
0.010
Why?
Dexamethasone
1
2002
34
0.010
Why?
Antiviral Agents
1
2002
50
0.010
Why?
Lung Neoplasms
1
2002
552
0.010
Why?
Moy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (199)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_